Diagnostic groups and short-term outcomes in suspected COVID-19 cases treated in an emergency department

F Javier Martín-Sánchez,Juan González Del Castillo,Adrián Valls Carbó,Amanda López Picado,Carmen Martínez-Valero,Juande D Miranda,Ana Chacón,Pedro López-Ayala,David Chaparro,Gabriel Cozar López,María Del Mar Suárez-Cadenas,Pablo Jerez Fernández,Enrique Del Toro,Eduardo Cardassay,Beatriz Angós,Cristina Díaz Del Arco,Esther Rodríguez Adrada,María Teresa Montalvo Moraleda,Carolina Espejo Paeres,Carlos Elvira,Miguel Ángel García Briñón,José Mª Leal Pozuelo,Luis Ortega,Cristina Fernández Pérez,Juan Jorge González Armengol

Emergencias

Abstract:Objectives: The primary objective was to describe the clinical characteristics and 30-day mortality rates in emergency department patients with coronavirus disease 2019 (COVID-19) in different diagnostic groupings. Material and methods: Secondary analysis of the COVID-19 registry compiled by the emergency department of Hospital Clínico San Carlos in Madrid, Spain. We selected suspected COVID-19 cases treated in the emergency department between February 28 and March 31, 2020. The cases were grouped as follows: 1) suspected, no polymerase chain reaction (PCR) test (S/no-PCR); 2) suspected, negative PCR (S/PCR-); 3) suspected, positive PCR (S/PCR+); 4) highly suspected, no PCR, or negative PCR (HS/no or PCR-); and 5) highly suspected, positive PCR (HS/PCR+). We collected clinical, radiologic, and microbiologic data related to the emergency visit. The main outcome was 30-day all-cause mortality. Secondary outcomes were hospitalization and clinical severity of the episode. Results: A total of 1993 cases (90.9%) were included as follows: S/no-PCR, 17.2%; S/PCR-, 11.4%; S/PCR+, 22.1%; HS/no PCR or PCR-, 11.7%; and HS/PCR+, 37.6%. Short-term outcomes differed significantly in the different groups according to demographic characteristics; comorbidity and clinical, radiographic, analytical, and therapeutic variables. Thirty-day mortality was 11.5% (56.5% in hospitalized cases and 19.6% in cases classified as severe). The 2 HS categories and the S/PCR+ category had a greater adjusted risk for 30-day mortality and for having a clinically severe episode during hospitalization in comparison with S/PCR- cases. Only the 2 HS categories showed greater risk for hospitalization than the S/PCR- cases. Conclusion: COVID-19 diagnostic groups differ according to clinical and laboratory characteristics, and the differences are associated with the 30-day prognosis.